American Capital Management Inc. Sells 7,992 Shares of Novanta Inc. $NOVT

American Capital Management Inc. reduced its stake in Novanta Inc. (NASDAQ:NOVT) by 2.1% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 373,874 shares of the technology company’s stock after selling 7,992 shares during the period. Novanta comprises approximately 2.4% of American Capital Management Inc.’s investment portfolio, making the stock its 17th largest position. American Capital Management Inc.’s holdings in Novanta were worth $44,158,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently made changes to their positions in NOVT. AQR Capital Management LLC increased its position in Novanta by 78.9% during the 1st quarter. AQR Capital Management LLC now owns 4,231 shares of the technology company’s stock worth $537,000 after purchasing an additional 1,866 shares in the last quarter. Goldman Sachs Group Inc. grew its stake in shares of Novanta by 1.6% during the first quarter. Goldman Sachs Group Inc. now owns 419,037 shares of the technology company’s stock worth $53,582,000 after buying an additional 6,533 shares during the last quarter. Jane Street Group LLC grew its stake in shares of Novanta by 1,762.5% during the first quarter. Jane Street Group LLC now owns 61,631 shares of the technology company’s stock worth $7,881,000 after buying an additional 58,322 shares during the last quarter. First Trust Advisors LP acquired a new position in shares of Novanta during the second quarter worth $528,000. Finally, Amundi increased its holdings in shares of Novanta by 2.0% during the second quarter. Amundi now owns 18,042 shares of the technology company’s stock worth $2,397,000 after buying an additional 347 shares in the last quarter. 98.35% of the stock is owned by institutional investors.

Insiders Place Their Bets

In other Novanta news, CEO Matthijs Glastra sold 6,500 shares of the stock in a transaction dated Thursday, July 2nd. The stock was sold at an average price of $161.13, for a total transaction of $1,047,345.00. Following the completion of the sale, the chief executive officer directly owned 29,761 shares in the company, valued at approximately $4,795,389.93. This trade represents a 17.93% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 1.20% of the company’s stock.

Novanta Trading Down 0.5%

NASDAQ:NOVT opened at $140.80 on Tuesday. Novanta Inc. has a 52 week low of $98.27 and a 52 week high of $171.85. The company has a debt-to-equity ratio of 0.15, a quick ratio of 2.69 and a current ratio of 3.56. The firm’s fifty day moving average is $155.42 and its 200-day moving average is $140.42. The firm has a market cap of $5.32 billion, a P/E ratio of 102.03 and a beta of 1.67.

Novanta (NASDAQ:NOVT) last announced its earnings results on Monday, May 11th. The technology company reported $0.81 earnings per share for the quarter, topping analysts’ consensus estimates of $0.78 by $0.03. The business had revenue of $257.71 million during the quarter, compared to the consensus estimate of $253.40 million. Novanta had a net margin of 5.35% and a return on equity of 12.06%. Novanta’s quarterly revenue was up 10.4% on a year-over-year basis. During the same quarter last year, the firm earned $0.74 earnings per share. Novanta has set its FY 2026 guidance at 3.500-3.650 EPS and its Q2 2026 guidance at 0.810-0.860 EPS. Equities analysts expect that Novanta Inc. will post 3.59 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several research firms recently weighed in on NOVT. Robert W. Baird set a $180.00 price objective on Novanta in a report on Tuesday, June 9th. Weiss Ratings restated a “hold (c-)” rating on shares of Novanta in a research report on Wednesday, July 15th. Finally, Wall Street Zen raised Novanta from a “hold” rating to a “buy” rating in a report on Saturday, June 27th. One analyst has rated the stock with a Buy rating and two have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus price target of $180.00.

Novanta Company Profile

Novanta, Inc (NASDAQ: NOVT) is a global technology company that designs and manufactures precision components, subsystems and software used in advanced photonics and motion control applications. The company serves customers in the medical device and advanced industrial markets, supplying critical technologies for diagnostics and therapeutic systems, semiconductor and electronics manufacturing, and scientific instrumentation. Novanta’s product portfolio includes laser control modules, optics, beam delivery systems, high-precision motors, actuators, stages, and fluidics solutions designed to meet stringent accuracy and reliability requirements.

Novanta’s Photonics segment delivers laser and energy delivery components that enable minimally invasive surgical procedures and diagnostic imaging.